CN110522711A - 一种贵妇膏及制备方法 - Google Patents

一种贵妇膏及制备方法 Download PDF

Info

Publication number
CN110522711A
CN110522711A CN201910447513.XA CN201910447513A CN110522711A CN 110522711 A CN110522711 A CN 110522711A CN 201910447513 A CN201910447513 A CN 201910447513A CN 110522711 A CN110522711 A CN 110522711A
Authority
CN
China
Prior art keywords
parts
oligopeptides
oil
lady
seed oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910447513.XA
Other languages
English (en)
Inventor
郭云辉
吴献华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangzhou Haodie Cosmetics Co Ltd
Original Assignee
Guangzhou Haodie Cosmetics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Haodie Cosmetics Co Ltd filed Critical Guangzhou Haodie Cosmetics Co Ltd
Priority to CN201910447513.XA priority Critical patent/CN110522711A/zh
Publication of CN110522711A publication Critical patent/CN110522711A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29Titanium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/673Vitamin B group
    • A61K8/675Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/925Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

一种贵妇膏及制备方法,包括:丙二醇、棕榈酸乙基己酯、矿脂、矿油、二氧化钛、异构十六烷烃、甘油、聚甘油‑2油酸酯、PEG‑30二聚羟基硬脂酸酯、山茶籽油、蛋黄油、微晶蜡、光果甘草根提取物、珍珠粉、谷胱甘肽、霍霍巴籽油、苯氧乙醇、羟苯甲酯、羟苯丙酯、含氘水、棕榈酰五肽‑5、三七提取物、蛇床子提起物、丹参提取物、胶原、透明质酸、寡肽‑1、寡肽‑5、寡肽‑2、光甘草啶、烟酰胺和传明酸。本发明所述贵妇膏集补水保湿、多肽修复及多种植物提取液的活血化瘀和清除热燥湿的功效,使得整个体系的功效作用显著。

Description

一种贵妇膏及制备方法
技术领域
本发明涉及化妆品技术领域,尤其涉及一种贵妇膏及制备方法。
背景技术
爱美是全球女性与生俱来的爱好,据不完全统计80%以上的女性拥有自己的化妆品,并在日常生活中应用这些化妆品。然而随着人口老龄化、环境污染等问题的日益突出,爱美女性的容颜所要面对的挑战越发的困难。各类化妆品中又以美白类的产品最为畅销,应用最为广泛。
黑色素其实是一种氨基酸衍生物,在每个人的体内都有。20-25岁是黑色素沉淀形成的活跃期,其存在于皮肤基底层的细胞中间,是一种叫“黑色素原生物质”的物质,也叫做“色素母细胞”。色素母细胞分泌麦拉宁色素,当紫外线(B波、A波)照射到皮肤上(B波即UVB作用于皮肤基底层),肌肤就会处于“自我防护”的状态,即由紫外线刺激麦拉宁色素,激活酪氨酸酶的活性,来保护皮肤细胞。多巴其实就是黑色素的前身,经酪氨酸氧化而成,释放出黑色素。黑色素又经由细胞代谢的层层移动,到了肌肤表皮层形成雀斑、晒斑、黑斑等形状了。
市面上流行的祛斑霜或美白霜一般用后皮肤干涩,或用后没效果功能单一,且无法通过活血化瘀和清除热燥的方式排出肌肤内的色素。
发明内容
为此,本发明提供一种贵妇膏及制备方法,用以克服现有技术中无法通过活血化瘀排除肌肤中色素的问题。
一方面,本发明提供一种种贵妇膏,其按重量份包括:
丙二醇5-10份、棕榈酸乙基己酯5-8份、矿脂5-10份、矿油3-5份、二氧化钛4-10份、异构十六烷烃5-10份、甘油3-5份、聚甘油-2油酸酯3-5份、PEG-30二聚羟基硬脂酸酯3-5份、山茶籽油2-3份、蛋黄油1-5份、微晶蜡1-2份、光果甘草根提取物0.2-2份、珍珠粉3-5份、谷胱甘肽0.2-0.5份、霍霍巴籽油1-3份、苯氧乙醇0.2-0.5份、羟苯甲酯0.2-0.4份、羟苯丙酯0.1-0.2份、含氘水10-20份、棕榈酰五肽-5 0.2-1份、三七提取物2-5份、蛇床子提起物3-5份、丹参提取物2-5份、胶原0.2-1份、透明质酸0.1-0.3份、寡肽-10.1-0.5份、寡肽-5 0.1-0.2份、寡肽-2 0.1-0.2份、光甘草啶0.1-0.2份、烟酰胺2-5份、传明酸1-3份。
优选地,所述贵妇膏按重量份包括:
丙二醇5份、棕榈酸乙基己酯5份、矿脂5份、矿油3份、二氧化钛4份、异构十六烷烃5份、甘油3份、聚甘油-2油酸酯3份、PEG-30二聚羟基硬脂酸酯3份、山茶籽油2份、蛋黄油1份、微晶蜡1份、光果甘草根提取物0.2份、珍珠粉3份、谷胱甘肽0.2份、霍霍巴籽油1份、苯氧乙醇0.2份、羟苯甲酯0.2份、羟苯丙酯0.1份、含氘水10份、棕榈酰五肽-5 0.2份、三七提取物2份、蛇床子提起物3份、丹参提取物2份、胶原0.2份、透明质酸0.1份、寡肽-1 0.1份、寡肽-50.1份、寡肽-2 0.1份、光甘草啶0.1份、烟酰胺2份、传明酸1份。
优选地,所述贵妇膏按重量份包括:
丙二醇10份、棕榈酸乙基己酯8份、矿脂10份、矿油5份、二氧化钛10份、异构十六烷烃10份、甘油5份、聚甘油-2油酸酯5份、PEG-30二聚羟基硬脂酸酯5份、山茶籽油3份、蛋黄油5份、微晶蜡2份、光果甘草根提取物2份、珍珠粉5份、谷胱甘肽0.5份、霍霍巴籽油3份、苯氧乙醇0.5份、羟苯甲酯0.4份、羟苯丙酯0.2份、含氘水20份、棕榈酰五肽-5 1份、三七提取物5份、蛇床子提起物5份、丹参提取物5份、胶原1份、透明质酸0.3份、寡肽-10.5份、寡肽-5 0.2份、寡肽-2 0.2份、光甘草啶0.2份、烟酰胺5份、传明酸3份。
优选地,所述贵妇膏按重量份包括:
丙二醇7份、棕榈酸乙基己酯6份、矿脂8份、矿油4份、二氧化钛8份、异构十六烷烃6份、甘油4份、聚甘油-2油酸酯4份、PEG-30二聚羟基硬脂酸酯4份、山茶籽油3份、蛋黄油3份、微晶蜡2份、光果甘草根提取物1.8份、珍珠粉4份、谷胱甘肽0.4份、霍霍巴籽油2份、苯氧乙醇0.3份、羟苯甲酯0.3份、羟苯丙酯0.2份、含氘水15份、棕榈酰五肽-5 0.8份、三七提取物4份、蛇床子提起物4份、丹参提取物3份、胶原0.8份、透明质酸0.2份、寡肽-1 0.3份、寡肽-50.2份、寡肽-2 0.1份、光甘草啶0.2份、烟酰胺4份、传明酸2份。
另一方面,本发明提供一种贵妇膏的制备方法,包括:
步骤1:将指定重量份的含氘水、丙二醇、甘油、增稠剂加入水锅搅拌,升高温灭菌,得到乳化液A;
步骤2:将指定重量份的普通乳化剂聚甘油-2油酸酯、PEG-30二聚羟基硬脂酸酯、山茶籽油、异构十六烷烃、微晶蜡、棕榈酸乙基己酯、矿脂、矿油、蛋黄油、霍霍巴籽油等油脂加入油锅中,加入二氧化钛、珍珠粉搅拌,后加入羟苯甲酯、羟苯丙酯加热升高温灭菌,得到油相B;
步骤3:将乳化液A抽往油相B中,均质,加入增稠乳化剂,均质,降温;
步骤4:降到40℃时,加入指定重量份的光果甘草根提取物、谷胱甘肽、三七提取液、蛇床子提取液、丹参提取液、胶原、透明质酸、寡肽-1、寡肽-5、寡肽-2、寡肽-1、棕榈酰五肽-5、寡肽-6、神经酰胺、烟酰胺、光甘草啶和传明酸;
步骤5:继续降温,加入指定重量份的1,2-己二醇和辛酰羟肟酸,搅拌,出料,陈化,检验,制得所述贵妇膏。
进一步地,所述步骤1中搅拌时间为10-20min,加热温度为80-85℃。
进一步地,所述步骤2中搅拌时间为10-20min,加热温度为80-85℃。
进一步地,所述步骤3中均质采用高速均质机,均质时间为10-30min,加入乳化剂后均质1-3min。
进一步地,所述步骤5中继续降温至36-39℃,搅拌时间为10-15min,陈化时间为15-30min。与现有技术相比,本发明的有益效果在于,本发明所述贵妇膏集补水保湿、多肽修复及多种植物提取液的活血化瘀和清除热燥湿的功效,使得整个体系的功效作用显著。
尤其,本发明利用蛋黄油、棕榈酰五肽-5的穿透性及可增加胶原蛋白的生成,同时添加的光甘草啶及传明酸、烟酰胺对黑色素的生成有着很好的抑制作用,四者共同作用即可美白又可修复肌肤。添加珍珠粉,补充肌肤所需微量元素,二氧化钛,日常使用中隔离UA+UB及紫外线,防止阳光的晒伤肌肤;
进一步地,本发明中的植物提取物有三七、蛇床子、丹参三种提取物;三七能祛瘀止血,又能活血散瘀;蛇床子有清热燥湿,祛风止痒;丹参具有活血化瘀、理气止痛的功效;这三种中药按比例混合可以活血化瘀,清除热燥湿,让皮肤更加健康;
进一步地,本发明中各组分功效如下:
光甘草啶:光甘草啶有美白黄金的美称,具有出色的抗炎、抗氧化和抗黑色素形成的作用,能深入皮肤内部并保持高活性,美白并高效抗氧化。有效抑制黑色素生成过程中多种酶的活性,特别是抑制酪胺酸酵素活性。同时还具有防止皮肤粗糙和抗炎、抗菌的功效。
三七提取液:含皂甙,主要为人参皂甙Rb1、Rg1、Rg2和少量人参皂甙Ra、Rb2、Rb和Re。此外,尚含黄酮甙淀粉、蛋白质油脂等;具有活血散瘀、祛瘀止血改善和加强冠脉微循环、抗炎、抗疲劳、抗肿瘤、镇痛和免疫调节作用。
蛇床子提取液:蛇床子提取物是伞形科植物蛇床子的果实提取而来,其有效成分含蒎烯、异缬草酸龙脑酯、欧芹酚甲醚二氢欧山芹醇、佛手柑内酯、蛇床子素、异茴芹素等,具有清热燥湿,祛风止痒的功效。
丹参提取液:主要成分为丹参酮IIA,丹酚酸B和隐丹参酮,丹参提取物主要有脂溶性非醌色素类化合物,如丹参酮ⅡA、丹参酮ⅡB、隐丹参酮及其异构体。尚含水溶性酚酸类成分如原儿茶醛、丹参素。其中,隐丹参酮是抗菌的有效成分;具有活血化瘀、理气止痛的功效。
传明酸:传明酸是一种蛋白酶抑制剂,能抑制蛋白酶对肽键水解的催化作用,从而阻止了发源性蛋白酶等酶的活性,进而抑制了黑斑部位的表皮细胞机能的混乱,并且抑制黑色素增强因子群,再彻底断绝因为紫外线照射而形成的黑色素发生的途径。即让黑斑不再变浓、扩大及增加,从而能有效地防止和改善皮肤的色素沉积。
具体实施方式
为了使本发明的目的和优点更加清楚明白,下面结合实施例对本发明作进一步描述;应当理解,此处所描述的具体实施例仅仅用于解释本发明,并不用于限定本发明。
下面根据各个实施例不同的配比进行说明。
实施例一
一种贵妇膏,其按重量份包括:
丙二醇5份、棕榈酸乙基己酯5份、矿脂5份、矿油3份、二氧化钛4份、异构十六烷烃5份、甘油3份、聚甘油-2油酸酯3份、PEG-30二聚羟基硬脂酸酯3份、山茶籽油2份、蛋黄油1份、微晶蜡1份、光果甘草根提取物0.2份、珍珠粉3份、谷胱甘肽0.2份、霍霍巴籽油1份、苯氧乙醇0.2份、羟苯甲酯0.2份、羟苯丙酯0.1份、含氘水10份、棕榈酰五肽-5 0.2份、三七提取物2份、蛇床子提起物3份、丹参提取物2份、胶原0.2份、透明质酸0.1份、寡肽-1 0.1份、寡肽-50.1份、寡肽-2 0.1份、光甘草啶0.1份、烟酰胺2份、传明酸1份。
本实施例所述贵妇膏的制备方法包括以下步骤:
步骤1:将指定重量份的含氘水、丙二醇、甘油、增稠剂加入水锅搅拌,升高温灭菌,得到乳化液A;
步骤2:将指定重量份的普通乳化剂聚甘油-2油酸酯、PEG-30二聚羟基硬脂酸酯、山茶籽油、异构十六烷烃、微晶蜡、棕榈酸乙基己酯、矿脂、矿油、蛋黄油、霍霍巴籽油等油脂加入油锅中,加入二氧化钛、珍珠粉搅拌,后加入羟苯甲酯、羟苯丙酯加热升高温灭菌,得到油相B;
步骤3:将乳化液A抽往油相B中,均质,加入增稠乳化剂,均质,降温;
步骤4:降到40℃时,加入指定重量份的光果甘草根提取物、谷胱甘肽、三七提取液、蛇床子提取液、丹参提取液、胶原、透明质酸、寡肽-1、寡肽-5、寡肽-2、寡肽-1、棕榈酰五肽-5、寡肽-6、神经酰胺、烟酰胺、光甘草啶和传明酸;
步骤5:继续降温,加入指定重量份的1,2-己二醇和辛酰羟肟酸,搅拌,出料,陈化,检验,制得所述贵妇膏。
其中,所述步骤1中搅拌时间为10min,加热温度为80℃;所述步骤2中搅拌时间为10min,加热温度为80℃;所述步骤3中均质采用高速均质机,均质时间为10min,加入乳化剂后均质1min;所述步骤5中继续降温至36℃,搅拌时间为10min,陈化时间为15min。
实施例二
一种贵妇膏,其按重量份包括:
丙二醇10份、棕榈酸乙基己酯8份、矿脂10份、矿油5份、二氧化钛10份、异构十六烷烃10份、甘油5份、聚甘油-2油酸酯5份、PEG-30二聚羟基硬脂酸酯5份、山茶籽油3份、蛋黄油5份、微晶蜡2份、光果甘草根提取物2份、珍珠粉5份、谷胱甘肽0.5份、霍霍巴籽油3份、苯氧乙醇0.5份、羟苯甲酯0.4份、羟苯丙酯0.2份、含氘水20份、棕榈酰五肽-5 1份、三七提取物5份、蛇床子提起物5份、丹参提取物5份、胶原1份、透明质酸0.3份、寡肽-10.5份、寡肽-5 0.2份、寡肽-2 0.2份、光甘草啶0.2份、烟酰胺5份、传明酸3份。
本实施例所述贵妇膏的制备方法与所述实施例一中的制备方法相同,其中,所述步骤1中搅拌时间为20min,加热温度为85℃;所述步骤2中搅拌时间为20min,加热温度为85℃;所述步骤3中均质采用高速均质机,均质时间为30min,加入乳化剂后均质3min;所述步骤5中继续降温至39℃,搅拌时间为15min,陈化时间为30min。
实施例三
一种贵妇膏,其按重量份包括:
丙二醇7份、棕榈酸乙基己酯6份、矿脂8份、矿油4份、二氧化钛8份、异构十六烷烃6份、甘油4份、聚甘油-2油酸酯4份、PEG-30二聚羟基硬脂酸酯4份、山茶籽油3份、蛋黄油3份、微晶蜡2份、光果甘草根提取物1.8份、珍珠粉4份、谷胱甘肽0.4份、霍霍巴籽油2份、苯氧乙醇0.3份、羟苯甲酯0.3份、羟苯丙酯0.2份、含氘水15份、棕榈酰五肽-5 0.8份、三七提取物4份、蛇床子提起物4份、丹参提取物3份、胶原0.8份、透明质酸0.2份、寡肽-1 0.3份、寡肽-50.2份、寡肽-2 0.1份、光甘草啶0.2份、烟酰胺4份、传明酸2份。
本实施例所述贵妇膏的制备方法与所述实施例一中的制备方法相同,其中,所述步骤1中搅拌时间为15min,加热温度为83℃;所述步骤2中搅拌时间为15min,加热温度为82℃;所述步骤3中均质采用高速均质机,均质时间为21min,加入乳化剂后均质2min;所述步骤5中继续降温至38℃,搅拌时间为13min,陈化时间为20min。
选用不同年龄段的女性使用上述三实施例制得的贵妇膏,并在30天后收取用户反馈。根据反馈可得:使用者在使用本发明所述贵妇膏以后肤质均得到明显改善,皮肤净白润滑,且未见皮肤发红、发疹、水疙等局部刺激反应。
至此,已经结合优选实施方式描述了本发明的技术方案,但是,本领域技术人员容易理解的是,本发明的保护范围显然不局限于这些具体实施方式。在不偏离本发明的原理的前提下,本领域技术人员可以对相关技术特征做出等同的更改或替换,这些更改或替换之后的技术方案都将落入本发明的保护范围之内。
以上所述仅为本发明的优选实施例,并不用于限制本发明;对于本领域的技术人员来说,本发明可以有各种更改和变化。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。

Claims (9)

1.一种贵妇膏,其特征在于,按重量份包括:
丙二醇5-10份、棕榈酸乙基己酯5-8份、矿脂5-10份、矿油3-5份、二氧化钛4-10份、异构十六烷烃5-10份、甘油3-5份、聚甘油-2油酸酯3-5份、PEG-30二聚羟基硬脂酸酯3-5份、山茶籽油2-3份、蛋黄油1-5份、微晶蜡1-2份、光果甘草根提取物0.2-2份、珍珠粉3-5份、谷胱甘肽0.2-0.5份、霍霍巴籽油1-3份、苯氧乙醇0.2-0.5份、羟苯甲酯0.2-0.4份、羟苯丙酯0.1-0.2份、含氘水10-20份、棕榈酰五肽-5 0.2-1份、三七提取物2-5份、蛇床子提起物3-5份、丹参提取物2-5份、胶原0.2-1份、透明质酸0.1-0.3份、寡肽-10.1-0.5份、寡肽-5 0.1-0.2份、寡肽-2 0.1-0.2份、光甘草啶0.1-0.2份、烟酰胺2-5份、传明酸1-3份。
2.根据权利要求1所述的贵妇膏,其特征在于,按重量份包括:
丙二醇5份、棕榈酸乙基己酯5份、矿脂5份、矿油3份、二氧化钛4份、异构十六烷烃5份、甘油3份、聚甘油-2油酸酯3份、PEG-30二聚羟基硬脂酸酯3份、山茶籽油2份、蛋黄油1份、微晶蜡1份、光果甘草根提取物0.2份、珍珠粉3份、谷胱甘肽0.2份、霍霍巴籽油1份、苯氧乙醇0.2份、羟苯甲酯0.2份、羟苯丙酯0.1份、含氘水10份、棕榈酰五肽-5 0.2份、三七提取物2份、蛇床子提起物3份、丹参提取物2份、胶原0.2份、透明质酸0.1份、寡肽-1 0.1份、寡肽-50.1份、寡肽-2 0.1份、光甘草啶0.1份、烟酰胺2份、传明酸1份。
3.根据权利要求1所述的贵妇膏,其特征在于,按重量份包括:
丙二醇10份、棕榈酸乙基己酯8份、矿脂10份、矿油5份、二氧化钛10份、异构十六烷烃10份、甘油5份、聚甘油-2油酸酯5份、PEG-30二聚羟基硬脂酸酯5份、山茶籽油3份、蛋黄油5份、微晶蜡2份、光果甘草根提取物2份、珍珠粉5份、谷胱甘肽0.5份、霍霍巴籽油3份、苯氧乙醇0.5份、羟苯甲酯0.4份、羟苯丙酯0.2份、含氘水20份、棕榈酰五肽-5 1份、三七提取物5份、蛇床子提起物5份、丹参提取物5份、胶原1份、透明质酸0.3份、寡肽-10.5份、寡肽-5 0.2份、寡肽-2 0.2份、光甘草啶0.2份、烟酰胺5份、传明酸3份。
4.根据权利要求1所述的贵妇膏,其特征在于,按重量份包括:
丙二醇7份、棕榈酸乙基己酯6份、矿脂8份、矿油4份、二氧化钛8份、异构十六烷烃6份、甘油4份、聚甘油-2油酸酯4份、PEG-30二聚羟基硬脂酸酯4份、山茶籽油3份、蛋黄油3份、微晶蜡2份、光果甘草根提取物1.8份、珍珠粉4份、谷胱甘肽0.4份、霍霍巴籽油2份、苯氧乙醇0.3份、羟苯甲酯0.3份、羟苯丙酯0.2份、含氘水15份、棕榈酰五肽-5 0.8份、三七提取物4份、蛇床子提起物4份、丹参提取物3份、胶原0.8份、透明质酸0.2份、寡肽-1 0.3份、寡肽-50.2份、寡肽-2 0.1份、光甘草啶0.2份、烟酰胺4份、传明酸2份。
5.一种贵妇膏的制备方法,其特征在于,包括:
步骤1:将指定重量份的含氘水、丙二醇、甘油、增稠剂加入水锅搅拌,升高温灭菌,得到乳化液A;
步骤2:将指定重量份的普通乳化剂聚甘油-2油酸酯、PEG-30二聚羟基硬脂酸酯、山茶籽油、异构十六烷烃、微晶蜡、棕榈酸乙基己酯、矿脂、矿油、蛋黄油、霍霍巴籽油等油脂加入油锅中,加入二氧化钛、珍珠粉搅拌,后加入羟苯甲酯、羟苯丙酯加热升高温灭菌,得到油相B;
步骤3:将乳化液A抽往油相B中,均质,加入增稠乳化剂,均质,降温;
步骤4:降到40℃时,加入指定重量份的光果甘草根提取物、谷胱甘肽、三七提取液、蛇床子提取液、丹参提取液、胶原、透明质酸、寡肽-1、寡肽-5、寡肽-2、寡肽-1、棕榈酰五肽-5、寡肽-6、神经酰胺、烟酰胺、光甘草啶和传明酸;
步骤5:继续降温,加入指定重量份的1,2-己二醇和辛酰羟肟酸,搅拌,出料,陈化,检验,制得所述贵妇膏。
6.根据权利要求5所述的贵妇膏的制备方法,其特征在于,所述步骤1中搅拌时间为10-20min,加热温度为80-85℃。
7.根据权利要求5所述的贵妇膏的制备方法,其特征在于,所述步骤2中搅拌时间为10-20min,加热温度为80-85℃。
8.根据权利要求5所述的贵妇膏的制备方法,其特征在于,所述步骤3中均质采用高速均质机,均质时间为10-30min,加入乳化剂后均质1-3min。
9.根据权利要求5所述的贵妇膏的制备方法,其特征在于,所述步骤5中继续降温至36-39℃,搅拌时间为10-15min,陈化时间为15-30min。
CN201910447513.XA 2019-05-27 2019-05-27 一种贵妇膏及制备方法 Pending CN110522711A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910447513.XA CN110522711A (zh) 2019-05-27 2019-05-27 一种贵妇膏及制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910447513.XA CN110522711A (zh) 2019-05-27 2019-05-27 一种贵妇膏及制备方法

Publications (1)

Publication Number Publication Date
CN110522711A true CN110522711A (zh) 2019-12-03

Family

ID=68659330

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910447513.XA Pending CN110522711A (zh) 2019-05-27 2019-05-27 一种贵妇膏及制备方法

Country Status (1)

Country Link
CN (1) CN110522711A (zh)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110269831A (zh) * 2019-06-27 2019-09-24 漳州美道夫电子商务有限公司 一种护肤膏及其制备方法
CN111616989A (zh) * 2020-06-23 2020-09-04 广州上官靖文化传播有限公司 一种可促进皮肤再生的修复乳液及其制作方法
US11571378B2 (en) 2021-01-22 2023-02-07 The Procter & Gamble Company Skin care composition and method of using the same
US11771637B2 (en) 2021-01-22 2023-10-03 The Procter & Gamble Company Skin care composition and method of using the same

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101254156A (zh) * 2007-03-01 2008-09-03 段亚东 一种化妆品组合物及其用途
CN104688654A (zh) * 2015-03-17 2015-06-10 欧诗漫生物股份有限公司 一种美白霜及其制备方法
CN109288753A (zh) * 2018-11-15 2019-02-01 广州博科健康科技集团有限公司 一种美白淡斑霜及其制备方法
CN109431836A (zh) * 2018-11-15 2019-03-08 广州博科健康科技集团有限公司 一种去疤痕组合物及其制备方法
CN110269831A (zh) * 2019-06-27 2019-09-24 漳州美道夫电子商务有限公司 一种护肤膏及其制备方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101254156A (zh) * 2007-03-01 2008-09-03 段亚东 一种化妆品组合物及其用途
CN104688654A (zh) * 2015-03-17 2015-06-10 欧诗漫生物股份有限公司 一种美白霜及其制备方法
CN109288753A (zh) * 2018-11-15 2019-02-01 广州博科健康科技集团有限公司 一种美白淡斑霜及其制备方法
CN109431836A (zh) * 2018-11-15 2019-03-08 广州博科健康科技集团有限公司 一种去疤痕组合物及其制备方法
CN110269831A (zh) * 2019-06-27 2019-09-24 漳州美道夫电子商务有限公司 一种护肤膏及其制备方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
广州好蝶化妆品有限公司: "美道夫养颜贵妇膏", 《网址:HTTP://FTBA.NMPA.GOV.CN:8181/FTBAN/ITOWNET/HZP_BA/FW/PZ.JSP?PROCESSID=201903011807107WOZA&NID=201903011807107WOZA》 *
张何,等: "《实用美容药物》", 31 August 2016, 华中科技大学出版社 *
马振友,等: "《皮肤美容化妆品制剂手册》", 31 January 2015, 中医古籍出版社 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110269831A (zh) * 2019-06-27 2019-09-24 漳州美道夫电子商务有限公司 一种护肤膏及其制备方法
CN111616989A (zh) * 2020-06-23 2020-09-04 广州上官靖文化传播有限公司 一种可促进皮肤再生的修复乳液及其制作方法
US11571378B2 (en) 2021-01-22 2023-02-07 The Procter & Gamble Company Skin care composition and method of using the same
US11771637B2 (en) 2021-01-22 2023-10-03 The Procter & Gamble Company Skin care composition and method of using the same
US11850299B2 (en) 2021-01-22 2023-12-26 The Procter & Gamble Company Skin care composition and method of using the same

Similar Documents

Publication Publication Date Title
Liu Natural products in cosmetics
CN110522711A (zh) 一种贵妇膏及制备方法
JP2018510860A (ja) 皮膚を処置するための方法
US20170281988A1 (en) Skin Care and Cosmetic Composition
CN108158914A (zh) 一种提亮肤色的精华液及其制备方法
CN103025307B (zh) 菊苣酸及衍生物用于调节皮肤色素沉着的用途
KR20090130801A (ko) 인삼씨 추출물을 함유하는 피부 외용제 조성물
CN106456526A (zh) 将白蔷薇提取物以及从中分离的加尔丹衍生化合物作为有效成分而包含的皮肤美白及皱纹改善用化妆品组合物
CN108524357A (zh) 一种含云木香根提取物的鲜活靓白面霜及其制备方法
CN108354874A (zh) 一种乌发组合物及应用
CN109288753A (zh) 一种美白淡斑霜及其制备方法
CN110787088A (zh) 一种淡化唇纹的基础组合物及其制备方法和应用
CN107157910A (zh) 一种具有双重保湿功效的护肤组合物及其制备方法与应用
EP3541478B1 (fr) Utilisation cosmétique, nutraceutique ou pharmaceutique préférentiellement dermatologique d'un extrait de feuilles de la plante lansium domesticum pour diminuer la pigmentation de la peu et/ou des annexes cutanées
BRPI0910630B1 (pt) Cosmetic or dermatological composition of myrtle extract for depigmenting skin, hair and / or hair, cosmetic process of bleaching and / or bleaching of the skin, hair and / or hair applying said composition, and use of myrtle extract in the manufacture of cosmetic composition or dermatological
CN110420160A (zh) 一种美白祛斑霜及制备方法
CN107970278A (zh) 莲雾水萃取物的水解产物及其制备方法与用途
KR101476004B1 (ko) 양파껍질과 비파잎 추출물을 포함하는 모발성장 촉진용 화장료 조성물
KR102154927B1 (ko) 클로로겐산, 페룰산, 레스베라트롤 및 스트렙토코쿠스 테르모필루스 발효물을 유효성분으로 함유하는 피부 개선용 기능성 화장료 조성물
TWI635873B (zh) 蓮霧水萃取物的水解產物及其製備方法與用途
CN111840192A (zh) 一种包含多种天然提取物的人参珍珠膏及其制备方法
KR101139373B1 (ko) 미백용 피부 미용 조성물 및 그의 제조방법 및 이를 함유한 마스크 팩
KR20200021709A (ko) 아스파라거스 추출물을 함유하는 멜라닌 세포 이동 촉진 조성물
KR102168533B1 (ko) 한약재 추출물을 포함하는 미백 또는 안색 개선용 화장료 조성물
KR20160003918A (ko) 한약재 추출물을 포함하는 피부 탄력 증진 또는 주름 개선용 화장료 조성물

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20191203

RJ01 Rejection of invention patent application after publication